Novo Nordisk Up 9.2% as Wegovy Pill Demand Sparks Amazon Delivery, $50 Copay Program
NVO•Novo Nordisk shares jumped 9.2% on May 7 as momentum builds behind the oral Wegovy pill, with Amazon Pharmacy launching same-day Ozempic delivery in nearly 3,000 U.S. cities. CMS will launch a Medicare GLP-1 Bridge program July 1, 2026, offering Wegovy at a $50 monthly copay through 2027.
1. Stock Reaction and Pill Momentum
Novo Nordisk shares surged 9.2% after investors reacted to strong demand signals for its oral Wegovy pill. The launch of a pill formulation is expected to accelerate patient adoption and diversify revenue beyond injection-based GLP-1 offerings.
2. Amazon Pharmacy Same-Day Ozempic Delivery
Amazon Pharmacy rolled out same-day delivery for oral Ozempic in nearly 3,000 U.S. cities, enhancing patient access and convenience. Plans to install pickup kiosks at select clinics aim to further streamline distribution and capture additional market share.
3. Medicare GLP-1 Bridge Program Launch
Beginning July 1, 2026, CMS will implement a Medicare GLP-1 Bridge program granting eligible beneficiaries access to Wegovy at a $50 monthly copay. The initiative covers all semaglutide doses and formulations through 2027, potentially boosting utilization among senior populations.
